Find the latest Adaro Andalan Indonesia Tbk. (AADI.JK) stock quote, history, news and other vital information to help you with your stock trading and investing.

Mar 26, 2025 · Kaken assumes ownership of Aadi Sub, including the Aadi Bioscience name, trademarks and the FYARRO®(sirolimus protein-bound particles for injectable suspension) (albumin-bound) …

Mar 18, 2025 · Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), formerly known as Aadi Bioscience, Inc., an oncology therapeutics company applying advanced technologies to established tumor …

(AADI.JK ) Jakarta - Delayed Quote•IDR 10,500.00 +150.00 (+1.45%) At close: March 17 at 4:11:59 PM GMT+7 Follow Comparisons Indicators Technicals Corporate events Draw Settings Select Chart ...

Mar 4, 2025 · Aadi Bioscience, Inc. (Nasdaq: AADI) ("Aadi"), an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver advances in cancer …

Mar 14, 2025 · Aadi Bioscience, Inc. (Nasdaq: AADI) ("Aadi") today announced that it will host a webcast to discuss fourth quarter and full-year 2024 financial results and provide recent corporate …

Dec 21, 2024 · Aadi Bioscience operates in the biotechnology industry, focusing on developing innovative antibody-drug conjugates (ADCs) for cancer treatment.

Discover historical prices for AADI.JK stock on Yahoo Finance. View daily, weekly or monthly format back to when Adaro Andalan Indonesia Tbk. stock was issued.

Mar 20, 2025 · Aadi Bioscience Inc (AADI) reports a strategic shift to Whitehawk Therapeutics, securing $100 million in financing and targeting advanced ADC technology to drive future growth.

Mar 3, 2025 · Aadi Bioscience, Inc. (NASDAQ: AADI), an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver advances in cancer …